RainTree Oncology Services

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

RainTree Oncology Services - overview

Location

San Diego, CA, US

Primary Industry

Healthcare Specialists

About

RainTree Oncology Services provides innovative healthcare solutions focused on enhancing oncology treatment efficiency and effectiveness through advanced software platforms. RainTree Oncology Services specializes in oncology services, offering software solutions designed to streamline clinical operations and enhance patient outcomes. The company is headquartered in San Diego, US. In March 2016, Cardinal Health acquired RainTree Oncology Services, with the financial terms of the deal undisclosed.


The CEO is Mike Martin. RainTree Oncology focuses on providing advanced software platforms that streamline clinical operations, manage patient data, and ensure regulatory compliance in the oncology sector. Their solutions address critical challenges faced by oncology practices, primarily targeting hospitals, outpatient cancer treatment centers, and academic research institutions in North America and Europe. RainTree Oncology generates revenue through subscription-based software services and partnerships with healthcare providers, structuring transactions for both B2B and direct-to-consumer models.


Clients, including hospitals and clinics, engage in annual contracts that encompass support, training, and software updates, allowing for recurring billing and ongoing access to essential tools for effective patient management. Despite the lack of specifics on new product launches or expansion into new markets, RainTree Oncology's future growth strategy will likely focus on leveraging the recent funding of USD 230,000 to enhance its product offerings and further penetrate the oncology sector. This will involve refining existing technologies and potentially designing new solutions to meet the evolving needs of healthcare providers. The company aims to utilize its resources effectively to bolster its market presence in North America and Europe following the acquisition by Cardinal Health.


Primary Industry

Healthcare Specialists

Sub Industries

Oncology/Cancer Treatment

Website

www.raintreeoncology.com

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.